Company DanDrit Biotech USA Inc OTC Bulletin Board
Equities
US2360781015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 24 | Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics | MT |
Apr. 18 | Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 18-01-22 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-20 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Joseph R. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
François Binette
COO | Chief Operating Officer | - | 22-04-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 19-12-31 |
Avram Miller
BRD | Director/Board Member | - | 23-10-10 |
James Sapirstein
BRD | Director/Board Member | 63 | 18-03-05 |
Director/Board Member | 60 | 23-10-03 | |
Director/Board Member | 78 | 23-10-03 | |
Carol Brosgart
BRD | Director/Board Member | 72 | 19-12-26 |
Rene Sindlev
CHM | Chairman | 61 | 11-01-17 |
Mark Dybul
CEO | Chief Executive Officer | 60 | 18-01-22 |
Jayne McNicol
BRD | Director/Board Member | 57 | 21-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 143,668,372 | 105,978,359 ( 73.77 %) | 0 | 73.77 % |
Stock B | 0 | 561,010 | 0 | 0 |
Company contact information
Renovaro, Inc.
1927 Paseo Rancho Castillo
90032-2012, Los Angeles
+45 39 17 98 40
http://www.enochianbio.comSector
1st Jan change | Capi. | |
---|---|---|
-1.42% | 104B | |
+7.05% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.51% | 16.36B | |
+7.41% | 14.39B | |
+37.47% | 12.37B |
- Stock Market
- Equities
- RENB Stock
- Stock
- Company DanDrit Biotech USA Inc